By  on February 24, 2017

The Textile Effects division of Huntsman Corp. said the Supreme People’s Court of China has rejected Shanghai Colva Dyestuff Industry Co. Ltd.'s request for a retrial of the patent infringement claim brought by Huntsman.In earlier decisions, the Shanghai Intermediate People’s Court and the Shanghai High People’s Court ruled that Colva had infringed on Huntsman’s Chinese patent by manufacturing and selling Colvazol Super Black LC-G and Colvazol Super Black LC-R. With the Supreme People’s Court’s decision, Huntsman said it has reached the final resolution of the patent infringement action against Colva.In a separate action that is pending before the High People's Court in Shanghai, Huntsman is seeking substantial damages of 231 million yuan, or $33.6 million, and an injunction against further infringement from Zhejiang Longsheng Group Co. Ltd., Zhejiang Keyong Chemical Co. Ltd. and Colva.Rohit Aggarwal, president of Singapore-based Huntsman Textile Effects, said, “We are extremely pleased with the Supreme People’s Court’s decision to protect and uphold valuable intellectual property rights of companies. This will spur Huntsman’s ongoing investments in cutting-edge technology to bring new and exciting innovation to our customers and the industry."Aggarwal said the Supreme People’s Court decision "sends a strong signal and demonstrates its commitment in safeguarding intellectual property rights of both local and multinational companies in China."Huntsman’s patented technology is innovation for producing deep black shades of fabric. It is used in Huntsman’s Novacron Super Black dyes. Novacron is a registered trademark of Huntsman Corp. or an affiliate in some, but not all countries.Huntsman Textile Effects manufactures high-quality dyes and chemicals for the textile and related industries, with operations in more than 90 countries and seven primary manufacturing facilities in China, Germany, India, Indonesia, Mexico and Thailand.Huntsman Corp. is a publicly traded global manufacturer and marketer of differentiated chemicals with 2016 revenues of about $10 billion.

To continue reading this article...

load comments
blog comments powered by Disqus